shutterstock.com
Dec 15, 2024, 18:38
Ahmed Kotb: Infection risk in CAR T-cell therapy
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company (KFSHI), posted on X:
“Infection risk in CAR T-cell therapy:
Early (<30d): Bacteria, fungi to Fluoroquinolones, antifungals
Prolonged (30–90d): Viruses
Late (>90d): Reactivations (HSV/VZV) Prophylaxis: Antiviral, antifungal, G-CSF, IVIG.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 15, 2024, 18:38
Dec 15, 2024, 18:31
Dec 15, 2024, 14:56
Dec 15, 2024, 14:56
Dec 15, 2024, 14:54
Dec 15, 2024, 14:52
Dec 15, 2024, 14:48